The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

Grieving After Most cancers: Recommendation for These Grieving and Supporting Them

Amid the grief that I've and proceed to take care of as a result of my sister’s loss of life from most...

Managing Vitamin Adjustments in Sufferers With Gastrointestinal Cancers

Throughout an interview with CURE, Dr. Tracy Proverbs-Singh, a gastrointestinal oncologist at John Theurer Most cancers Middle, mentioned how she helps sufferers...

The Emotional Aspect of Most cancers Care Past Medical Therapy

Dr. Ariel Ostad spoke with CURE in regards to the emotional, psychological, and day-to-day burdens that always accompany a pores and skin...

FDA Approves Bigger Nelarabine Vial for Some Leukemias and Lymphomas

The U.S. Meals and Drug Administration (FDA) has permitted a bigger vial measurement of nelarabine injection (SH-111) for the remedy of T-cell...

FDA Quick Tracks LBL-034 in Relapsed or Refractory A number of Myeloma

The U.S. Meals and Drug Administration has granted quick observe designation to the investigational remedy LBL-034 to facilitate the event of a...

Hot Topics